Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, March 2009, p. 423-426, Vol. 16, No. 3
1071-412X/09/$08.00+0 doi:10.1128/CVI.00009-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
3)-β-D-Glucan as an Adjunct to Diagnosis in a Mixed Population with Uncommon Proven Invasive Fungal Diseases or with an Unusual Clinical Presentation
Servicio de Microbiología, Hospital Severo Ochoa, Leganés, Madrid,1 Unidad de Micología, Departamento de Microbiología, Hospital Universitario 12 de Octubre, Madrid,2 Departamento de Enfermería I, Universidad del País Vasco, Lejona, Vizcaya,3 Departamento de Inmunología, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco, Lejona, Vizcaya, Spain4
Received 15 September 2008/ Accepted 13 January 2009
This single-center observational prospective study evaluated the performance of (1
3)-β-D-glucan as an adjunct diagnostic tool in 12 patients with proven invasive fungal disease with different risk factors. The infections were due to either uncommon fungal pathogens such as dematiaceous molds (Scedosporium apiospermum, Alternaria infectoria, and Cladosporium macrocarpum) and hyaline septate molds (Fusarium solani and Blastoschizomyces capitatus) or Aspergillus spp. with unusual clinical presentations.
Published ahead of print on 21 January 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»